Literature DB >> 16700505

Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8.

Xin Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16700505     DOI： 10.1007/0-387-32824-6_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  15 in total

1.  Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes.

Authors:  Chutian Shu; Hu Ge; Michael Song; Jyun-Hong Chen; Huimin Zhou; Qu Qi; Feng Wang; Xifeng Ma; Xiaolei Yang; Genyan Zhang; Yanwei Ding; Dapeng Zhou; Peng Peng; Cheng-Kon Shih; Jun Xu; Frank Wu
Journal:  ACS Med Chem Lett       Date:  2014-06-16       Impact factor: 4.345

Review 2.  The intrinsic disorder alphabet. III. Dual personality of serine.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-17

3.  Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Authors:  Nicole E B Skinner; Matthew S Wroblewski; Julie A Kirihara; Gary L Nelsestuen; Elizabeth R Seaquist
Journal:  Diabetes Ther       Date:  2015-07-22       Impact factor: 2.945

4.  Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Authors:  Devin Abrahami; Antonios Douros; Hui Yin; Oriana Hoi Yun Yu; Christel Renoux; Alain Bitton; Laurent Azoulay
Journal:  BMJ       Date:  2018-03-21

5.  Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS).

Authors:  Eyal Leibovitz; Shmuel Gottlieb; Ilan Goldenberg; Natalie Gevrielov-Yusim; Shlomi Matetzky; Dov Gavish
Journal:  Cardiovasc Diabetol       Date:  2013-03-28       Impact factor: 9.951

6.  Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.

Authors:  E Tarantola; V Bertone; G Milanesi; E Capelli; A Ferrigno; D Neri; M Vairetti; S Barni; I Freitas
Journal:  Eur J Histochem       Date:  2012-10-08       Impact factor: 3.188

7.  Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.

Authors:  Seyung Chung; Sami Dwabe; Yayha Elshimali; Hemlata Sukhija; Clement Aroh; Jaydutt V Vadgama
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

8.  A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.

Authors:  Hee Young Kim; Jong-Ik Hwang; Mi Jin Moon; Jae Young Seong
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25

9.  The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients.

Authors:  Nicol Poncina; Mattia Albiero; Lisa Menegazzo; Roberta Cappellari; Angelo Avogaro; Gian Paolo Fadini
Journal:  Cardiovasc Diabetol       Date:  2014-05-14       Impact factor: 9.951

10.  Comparative genome analysis of Prevotella intermedia strain isolated from infected root canal reveals features related to pathogenicity and adaptation.

Authors:  Yunfeng Ruan; Lu Shen; Yan Zou; Zhengnan Qi; Jun Yin; Jie Jiang; Liang Guo; Lin He; Zijiang Chen; Zisheng Tang; Shengying Qin
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.